106 related articles for article (PubMed ID: 15492988)
1. Implication of tumstatin in tumor progression of human bronchopulmonary carcinomas.
Caudroy S; Cucherousset J; Lorenzato M; Zahm JM; Martinella-Catusse C; Polette M; Birembaut P
Hum Pathol; 2004 Oct; 35(10):1218-22. PubMed ID: 15492988
[TBL] [Abstract][Full Text] [Related]
2. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Hamano Y; Kalluri R
Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
[TBL] [Abstract][Full Text] [Related]
3. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
Maeshima Y; Colorado PC; Kalluri R
J Biol Chem; 2000 Aug; 275(31):23745-50. PubMed ID: 10837460
[TBL] [Abstract][Full Text] [Related]
4. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin.
Hamano Y; Zeisberg M; Sugimoto H; Lively JC; Maeshima Y; Yang C; Hynes RO; Werb Z; Sudhakar A; Kalluri R
Cancer Cell; 2003 Jun; 3(6):589-601. PubMed ID: 12842087
[TBL] [Abstract][Full Text] [Related]
5. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
6. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.
Maeshima Y; Yerramalla UL; Dhanabal M; Holthaus KA; Barbashov S; Kharbanda S; Reimer C; Manfredi M; Dickerson WM; Kalluri R
J Biol Chem; 2001 Aug; 276(34):31959-68. PubMed ID: 11399763
[TBL] [Abstract][Full Text] [Related]
8. Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model.
Chung IS; Son YI; Ko YJ; Baek CH; Cho JK; Jeong HS
Oral Oncol; 2008 Dec; 44(12):1118-26. PubMed ID: 18485794
[TBL] [Abstract][Full Text] [Related]
9. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.
Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A
Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256
[TBL] [Abstract][Full Text] [Related]
10. Reduction of tumstatin in asthmatic airways contributes to angiogenesis, inflammation, and hyperresponsiveness.
Burgess JK; Boustany S; Moir LM; Weckmann M; Lau JY; Grafton K; Baraket M; Hansbro PM; Hansbro NG; Foster PS; Black JL; Oliver BG
Am J Respir Crit Care Med; 2010 Jan; 181(2):106-15. PubMed ID: 19875687
[TBL] [Abstract][Full Text] [Related]
11. The expression of tumstatin is down-regulated in renal carcinoma.
Xu CX; Liu XX; Hou GS; Yan YF; Chen SM; Wang W; Jiang GS; Liu B; Xin JX
Mol Biol Rep; 2010 Jun; 37(5):2273-7. PubMed ID: 19688274
[TBL] [Abstract][Full Text] [Related]
12. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W
IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice.
Miyoshi T; Hirohata S; Ogawa H; Doi M; Obika M; Yonezawa T; Sado Y; Kusachi S; Kyo S; Kondo S; Shiratori Y; Hudson BG; Ninomiya Y
FASEB J; 2006 Sep; 20(11):1904-6. PubMed ID: 16877525
[TBL] [Abstract][Full Text] [Related]
14. Modified basement membrane composition during bronchopulmonary tumor progression.
Catusse C; Polette M; Coraux C; Burlet H; Birembaut P
J Histochem Cytochem; 2000 May; 48(5):663-9. PubMed ID: 10769050
[TBL] [Abstract][Full Text] [Related]
15. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin.
Maeshima Y; Manfredi M; Reimer C; Holthaus KA; Hopfer H; Chandamuri BR; Kharbanda S; Kalluri R
J Biol Chem; 2001 May; 276(18):15240-8. PubMed ID: 11278365
[TBL] [Abstract][Full Text] [Related]
16. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.
Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO
Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.
Sudhakar A; Boosani CS
Pharm Res; 2008 Dec; 25(12):2731-9. PubMed ID: 18551250
[TBL] [Abstract][Full Text] [Related]
18. Tumstatin transfected into human glioma cell line U251 represses tumor growth by inhibiting angiogenesis.
Ye HX; Yao Y; Jiang XJ; Yuan XR
Chin Med J (Engl); 2013; 126(9):1720-5. PubMed ID: 23652057
[TBL] [Abstract][Full Text] [Related]
19. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
20. Development of an ELISA for quantification of tumstatin in serum samples and tissue extracts of patients with lung carcinoma.
Luo YQ; Li-JuanYao ; Zhao L; Sun AY; Dong H; Du JP; Wu SZ; Hu W
Clin Chim Acta; 2010 Apr; 411(7-8):510-5. PubMed ID: 20064495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]